ABO hemolytic disease of the newborn

ABO he·mo·lyt·ic dis·ease of the new·born

erythroblastosis fetalis resulting from maternal-fetal incompatibility with respect to an antigen of the ABO blood group; the fetus possesses A or B antigen (or both), that is lacking in the mother, and the mother produces immune antibody, that causes hemolysis of fetal erythrocytes.
References in periodicals archive ?
Cariani L, Romano EL, Martinez N, Mobano R, Suarez G, Ruiz I, Sovano A: ABO hemolytic disease of the newborn (ABO-HDN): factors influencing its severity and incidence in Venezuela.
The jaundice was felt to be due to ABO hemolytic disease of the newborn (mother O negative, newborn B negative, direct antiglobulin test positive) and was treated successfully by a 36-h regimen of phototherapy.
Intravenous immunoglobulin G (IVIG) therapy for significant hyperbilirubinemia in ABO hemolytic disease of the newborn.
Role of antibody dependent cell mediated cytotoxicity in ABO hemolytic disease of the newborn.